- Home
- ZCMD vs EDSA Comparison
ZCMD vs EDSA Comparison
Compare ZCMD & EDSA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ZCMD
- EDSA
- Stock Information
- Founded
- ZCMD 2012
- EDSA 2015
- Country
- ZCMD China
- EDSA Canada
- Employees
- ZCMD N/A
- EDSA N/A
- Industry
- ZCMD Other Consumer Services
- EDSA Biotechnology: Pharmaceutical Preparations
- Sector
- ZCMD Real Estate
- EDSA Health Care
- Exchange
- ZCMD Nasdaq
- EDSA Nasdaq
- Market Cap
- ZCMD 6.2M
- EDSA 6.1M
- IPO Year
- ZCMD 2020
- EDSA N/A
- Fundamental
- Price
- ZCMD $2.00
- EDSA $1.90
- Analyst Decision
- ZCMD
- EDSA Strong Buy
- Analyst Count
- ZCMD 0
- EDSA 1
- Target Price
- ZCMD N/A
- EDSA $21.00
- AVG Volume (30 Days)
- ZCMD 26.5K
- EDSA 31.2K
- Earning Date
- ZCMD 01-01-0001
- EDSA 02-07-2025
- Dividend Yield
- ZCMD N/A
- EDSA N/A
- EPS Growth
- ZCMD N/A
- EDSA N/A
- EPS
- ZCMD N/A
- EDSA N/A
- Revenue
- ZCMD $17,406,104.00
- EDSA N/A
- Revenue This Year
- ZCMD N/A
- EDSA N/A
- Revenue Next Year
- ZCMD N/A
- EDSA N/A
- P/E Ratio
- ZCMD N/A
- EDSA N/A
- Revenue Growth
- ZCMD 1.01
- EDSA N/A
- 52 Week Low
- ZCMD $1.00
- EDSA $1.69
- 52 Week High
- ZCMD $5.50
- EDSA $5.99
- Technical
- Relative Strength Index (RSI)
- ZCMD 61.05
- EDSA 37.11
- Support Level
- ZCMD $1.91
- EDSA $1.73
- Resistance Level
- ZCMD $1.47
- EDSA $2.55
- Average True Range (ATR)
- ZCMD 0.27
- EDSA 0.18
- MACD
- ZCMD 0.07
- EDSA 0.03
- Stochastic Oscillator
- ZCMD 61.24
- EDSA 25.58
About ZCMD Zhongchao Inc.
ZHONGCHAO Inc is a Cayman Islands-based provider of healthcare information, education, and training services. It provides services to healthcare professionals and the public in China. It offers online and onsite health information services, healthcare education programs, and healthcare training products, consisting of clinical practice training, open classes of popular medical topics, interactive case studies, academic conferences and workshops, continuing education courses, and articles and short videos with educational healthcare content.
About EDSA Edesa Biotech Inc.
Edesa Biotech Inc is a biotechnology company focused on inflammatory and immune-related diseases. It is involved in exploring novel ways to treat these diseases, including alternatives to topical steroids, which can have side effects. The company's product candidate, EB01, is a non-steroidal, anti-inflammatory treatment for chronic allergic contact dermatitis. The company operates in a single segment: research and development, manufacturing, and commercialization of innovative pharmaceutical products. The company's EB05 candidate is a monoclonal antibody therapy for hospitalized COVID-19 patients.